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Diagnostic test accuracy of informant based tools to diagnose dementia in older 
hospital patients with delirium: A prospective cohort study  
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Abstract 
Background:  Delirium and dementia co-exist commonly in hospital.  Older people with 
delirium have high rates of undiagnosed dementia, but delirium affects the use of cognitive 
testing in dementia diagnosis.  Novel methods to detect dementia in delirium are needed.  The 
purpose of the study was to investigate the diagnostic test accuracy of informant tools to 
detect dementia in hospitalised older people with delirium. 
Methods:  The presence of dementia on admission was assessed using the short form of the 
Informant Questionnaire of Cognitive decline in the Elderly (IQCODE-SF) and Alzheimer’s 
Disease 8 (AD8) in people over 70 years old with delirium.  Reference standard diagnosis 
was made using Diagnostic and Statistical Manual of Mental Disorders fourth edition (DSM-
IV) criteria at three months. The main outcome measures were the diagnostic test accuracy of 
the IQCODE-SF and the AD8 in diagnosing DSM-IV dementia.   
Results:  Dementia prevalence at 3 months was 61%.  The area under the receiver operating 
characteristic curve (AUROC) was 0.93 (p<0.0005) for admission IQCODE-SF and 0.91 
(p<0.0005) for admission AD8.  An IQCODE-SF test result of >3.82 on admission had a 
sensitivity of 0.91 (0.79-0.97) and specificity of 0.93 (0.76-0.99) for detecting dementia.  An 
AD8 of >6 had a sensitivity of 0.83 (0.69-0.92) and specificity of 0.90 (0.72-0.97) for 
detecting dementia. 
Conclusion:  The IQCODE-SF and AD8 are sensitive and specific tools to detect prior 
dementia in older people with delirium.  The routine use of either tool in practice could have 
important clinical impact, by improving the recognition and hence management of those with 
dementia. 
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Introduction 
Dementia is a chronic neurodegenerative disease characterised by progressive cognitive 
decline, amnesic deficits and functional deficits [1].  Dementia is common among older 
hospital patients.  In acute medical admissions cognitive impairment affects 50% [2] and 
dementia up to 42% [3, 4].  Older patients with dementia have higher rates of adverse events 
in hospital [5] as well as higher mortality and institutionalisation [6].  However, dementia in 
this population is under-recognised, with up to a half of older patients in hospital with 
dementia not having a recognised diagnosis [3].  
Delirium is a severe neuropsychiatric syndrome characterised by an acute change in 
cognition, attentional deficits and altered arousal [7]. Delirium is also common in older 
hospital inpatients, affecting 15-25% of acute admissions [2, 8].  Apart from age, cognitive 
impairment is the most important risk factor for delirium [9]. Therefore, older patients with 
delirium are a key target population to improve identification of dementia within the general 
hospital.   
Few traditional performance based assessments (cognitive tests) for dementia have been 
validated in the general hospital and they are not valid in the context of patients with delirium 
[10].  As delirium, by definition, is associated with an acute cognitive change from baseline, 
novel strategies to identify dementia in delirium are required.  Brief informant based 
screening tools with relatives and carers are thoroughly validated for community use [11] but 
have only been validated in a single study in hospital inpatients [12]  and not in those with 
delirium.  
The report aimed to assess the diagnostic test accuracy of two informant tools to detect prior 
dementia in older patients with current delirium. 
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Methods 
Recruitment 
Patients aged 70 years and over with an unplanned medical admission to a United Kingdom 
university hospital between March 2013 and November 2014 were screened for delirium.  
The screening used the Confusion Assessment Method (CAM) [13], Abbreviated Mental Test 
Score (AMTS) [14], the Digit Span test, and a detailed review of the medical notes.  An 
expert geriatrician (TAJ) completed all screening.  If participants met the Diagnostic and 
Statistical Manual of Mental Disorders fourth edition (DSM-IV-TR) criteria for delirium [15] 
they were eligible for the study. Potential participants who were unable to communicate 
because of severe sensory impairment or inability to speak in English were excluded, as were 
those deemed to be at risk of imminent death.   
Patients with delirium were then invited to participate.  Informed consent was sought from 
the potential participant if they had capacity. For those who lacked capacity to give informed 
consent, the next of kin was consulted in accordance with the provisions of the Mental 
Capacity Act with respect to participation in research, and they were also approached to act 
themselves as informants in the study.  Informed consent was then gained from the 
informants. 
An informant interview enquired about previous diagnosis of dementia or cognitive 
impairment.  The informant was then asked to complete two rating scales in order.  First the 
short form of the Informant Questionnaire of Cognitive Decline in the Elderly (IQCODE-
SF)[16] and second, the ‘AD8: The Washington University Dementia Screening Test’, also 
5 
 
referred to as the Eight-item Interview to Differentiate Aging and Dementia (AD8) [17].  
These were chosen as they are freely available and have face validity.  After explanation of 
the tests, they were then completed in private and placed in an envelope to ensure appropriate 
blinding.  
Informant tools 
The IQCODE-SF asks the informant to rate changes in cognition, memory and behaviours 
over a 10-year period.  It has been validated in both primary care settings [11], community 
settings [18] and secondary care settings [19] to diagnose dementia.  It takes about 10 
minutes to complete.  The scale consists of 16 items rated one to five where higher scores 
indicate a greater degree of cognitive impairment, from which a mean is derived (also 
ranging from one to five).  In instances where ratings were missing for an item, a mean score 
was calculated from the items that were completed. The introductory wording was changed to 
‘Now we want you to remember what your friend or relative was like 10 years ago and to 
compare it with what he/she was like before they got the illness that brought them to 
hospital’.  
The AD8 is a shorter screening informant interview, asking the informant to rate memory and 
thinking changes over a few years, rating eight items either yes, no or don’t know.  It takes 
five minutes to complete and has been found to be sensitive and specific to dementia in a 
memory clinic population [65].  The test is scored from zero to a maximum of eight, where 
higher scores indicate a greater degree of cognitive impairment.  Missing values were 
assumed to be ‘don’t know’, so scored as zero. 
Reference Standard 
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At 3 months an assessment in survivors was undertaken to determine a reference diagnosis of 
dementia at the time of index admission.  The assessment was carried out by TAJ at the 
patient’s own home or hospital if they were still an inpatient.  The assessment was carried out 
blinded to the results of the IQCODE-SF and AD8. It is not possible to diagnose DSM-IV 
dementia in the presence of delirium so follow-up at three months was chosen as the best 
balance to allow recovery from delirium and ensuring an accurate diagnosis of dementia at 
the index admission.  The presence of persistent delirium was first assessed for using DSM-
IV-TR criteria. If no delirium was present a standardised history and examination, including 
the Addenbrooke’s Cognitive Examination III (ACEIII) [20], was performed to establish the 
presence or absence of dementia at the time of index admission (before the onset of the 
delirium). Dementia and subtype was diagnosed using the DSM-IV criteria[21]: (1) the 
development of multiple cognitive deficits, including memory impairment, and (2) the 
impairment is sufficiently severe to cause impairment in occupational or social function. To 
make the diagnosis of dementia at the index admission the symptoms of cognitive decline had 
to have been present for at least 6 months prior to the admission with delirium.  
Statistical analysis 
Receiver operating characteristic curves were generated for both tests and a calculation of the 
area under the curve (AUROC) made.  Sensitivity, specificity, the positive likelihood ratio 
(LR+), and the negative likelihood ratio (LR-) were calculated from the best cut-offs.  In 
evaluating the relative misclassification costs in this population we selected cut-offs that 
minimized false positive diagnoses, reducing the burden of potentially stressful and 
unnecessary further investigation.  Data were analysed using IBM SPSS version 20 for 
Windows.   
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Please see Appendix 1 in the supplementary data on the journal website 
(http://www.ageing.oxfordjournals.org/) for details of the power calculations. 
All assessments were carried out by a single trained assessor (TAJ).  The protocol was 
assessed and approved by the Bradford Ethics Committee, part of the Yorkshire and Humber 
National research and Ethics Service (Ref: 12/YH/0534).   The study was reported using the 
Standards for Reporting of Diagnostic Accuracy (STARD) statement with specific reference 
to studies of diagnostic test accuracy in dementia [22, 23] (Check list and flow chart available 
in Appendix 2 in the supplementary data) 
 
Results 
Delirium was diagnosed in 228 (17.2%) of 1327 older people screened for delirium.  125 of 
this group of 228 (54.8%) were recruited.  The main reason for non-recruitment was the lack 
of an available consultee or informant (57/228, 25%).  22/228 (10%) were deemed at risk of 
imminent death, 15/228 (7%) were not able to communicate in English, the consultee 
declined participation in 2/228 (1%) and 7/228 (3%) had been previously recruited.   
Of the 125 recruited, 77 (62%) had a full assessment for the reference standard diagnosis.  
25/125 (20%) had died, 10/125 (8%) declined the follow-up visit, 8/125 (6%) were not 
contactable for an assessment, and 5/125 (4%) had persistent delirium at assessment. There 
was no difference in age, gender or admission dementia status between those assessed for 
dementia at 3 months and those not.  The mean age of the final sample assessed for reference 
criterion diagnosis of dementia was 84.4 and 69% were female.  Participant flow through the 
study is illustrated in figure 1. 
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At three month assessment 47/77 (61%) were diagnosed with dementia, 14/77 (18%) were 
diagnosed with MCI, and 16/77 (21%) had no cognitive impairment.  Of those with dementia, 
this was newly diagnosed in 17/47 (36%).   
In diagnosing DSM-IV dementia the AUROC curve for the admission IQCODE-SF was 0.93 
(95% CI 0.86-1.00, p<0.0005) and for the admission AD8 it was 0.91 (95% CI 0.83-0.98, 
p<0.0005).  There was no statistical difference between the AUROC curves (z=0.45, p=0.65) 
[24].  The selected cut off of >3.82 for the IQCODE-SF gave a sensitivity of 0.91, a 
specificity of 0.93, LR+ of 13.72 and a LR- of 0.09.  The selected cut off of  >6 for the AD8 
gave a sensitivity of 0.83, a specificity of 0.90, a LR+ of 8.30 and a LR- of 0.19. 
The traditional cut off of the IQCODE-SF for diagnosing dementia in the general hospital 
[25] is ≥3.44.  Using this cut off gave a greater sensitivity of 0.98 at the expense of a lower 
specificity of 0.67.   
Table 1 illustrates the diagnostic test accuracy values for the IQCODE-SF and AD8 including 
confidence intervals at various cut-offs.  Please see Figure 1 in the supplementary data on the 
journal website http://www.ageing.oxfordjournals.org/ for the ROC curves for the IQCODE-
SF and AD8.   
 
Discussion 
The main new finding in this study is that we found excellent diagnostic test accuracy of the 
IQCODE-SF and AD8 in diagnosing dementia in older people presenting with delirium.   
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Specifically, we found that the IQCODE-SF and AD8 had excellent sensitivity, specificity 
and discriminatory ability.  An AUROC of greater than 0.9 is considered excellent.  Based on 
the findings from this study, taking 100 older people with delirium, IQCODE-SF at a cut off 
of >3.82 would correctly identify 56 of the 61 with dementia and would falsely imply a 
diagnosis of dementia in 3 of the 39 without dementia.  Interpreting the likelihood ratios of 
the IQCODE-SF at a cut off of >3.82 to diagnose dementia, a positive test is 13 times more 
likely to occur in someone with dementia rather than someone without dementia.  A negative 
test is 0.07 times less likely to occur in someone with dementia rather than someone without.  
This indicates good discrimination after a test has been performed.  A positive likelihood 
ratio of greater than 10 and a negative likelihood ratio of less than 0.1 indicates a test is 
useful [26].   
Neither the IQCODE-SF nor the AD8 have previously been validated to diagnose dementia 
in patients with delirium.  One previous study has examined the diagnostic test accuracy of 
the IQCODE-SF to diagnose dementia in older hospital inpatients, excluding those with 
delirium.  This reported a sensitivity of 1.00 and specificity of 0.86 for detecting DSM-IIIR 
dementia at a cut-off of >3.44 [12].  They report at ≥3.76 cut off a sensitivity of 0.92 and 
specificity of 0.93 for the IQCODE-SF, which are very similar to our reported values. It is 
also worth noting that the prevalence of dementia was much lower (10%) in this study.  
Although the IQCODE-SF has not been formally assessed in people with delirium, it is 
commonly used as a proxy for previous cognitive impairment in delirium research using 
different cut offs.  A cut off of  >3.5 has been used in a general hospital population [27] and 
our findings suggest these cut offs may be too low.    
Although both tests have similar diagnostic accuracy both have advantages and 
disadvantages.  The AD8 is simpler and quicker to complete, however it has a higher number 
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of false positives.  The IQCODE-SF still only takes a maximum of 10 minutes to complete 
and the extra detail gathered may be of clinical relevance.  The IQCODE-SF has been 
translated into 14 languages.  Both are freely available without cost [28, 29].  On balance we 
would recommend using the IQCODE-SF at a cut off of >3.82 to detect dementia. 
The study has important strengths and limitations.  The reported prevalence of delirium of 
17.9% is similar to previous studies in acute admissions [8] indicating the screening was 
robust.  We recognise the difficulty in diagnosing dementia among patients in hospital with 
delirium, so strict reference criteria were applied by an experienced and trained specialist 
assessor.  The assessor was blinded to the index test result. We accept that the diagnosis of 
dementia before the hospital admission with delirium could be affected by recall bias, and the 
presence of post-delirium cognitive impairment. However, the assessor aimed to take this into 
account when conducting his assessment. The diagnosis of prior cognitive impairment did not 
rely exclusively on cognitive testing at three months, but also on the clinical history.  
Therefore, we believe the findings to be robust and are representative of a real world general 
hospital.   The study recruited to the appropriately powered sample size.  The study did not 
recruit all patients diagnosed with delirium, the main reason being the lack of an available 
consultee and/or informant.  However, there were no gender or age differences between those 
recruited and those not.  Not all participants were available for reference diagnosis 
assessment at 3 months.  The main reason was mortality, with 25 (20%) having died prior 
follow-up.  This is in keeping with the expected mortality of delirium [27] and importantly 
higher mortality would be expected in those with dementia.  
The other factor that could reduce the generalisability of our findings is the non-availability 
of an informant  In our study one-quarter (57/228) of patients with delirium had no informant 
available, so this may affect the utility of informant tools in practice. However, the 
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recruitment of an informant in our study was time limited so we feel in real world practice 
this proportion would be lower. There was no difference in age and gender between the 
recruited and non-recruited groups.  The informant information may also be affected by recall 
bias as characteristics of the informant may influence the result such as depression or 
cognitive impairment.  However the strength of an informant tools is that it to some extent 
mitigates problems with pre-existing educational background, culture or language difficulties. 
The significance of our findings to the research community is that the IQCODE-SF or AD8 at 
validated cut offs can now be used to robustly identify prior dementia in studies of delirium 
cohorts in general hospital.   
Our findings could impact significantly on clinical practice, given the high prevalence of 
delirium and unrecognised dementia in the general hospital.  Figure 2 is a flow chart 
extrapolating our diagnostic and prevalence data to a hypothetical acute hospital with 1000 
beds.  Although we acknowledge there are differing views, a timely diagnosis of dementia 
during hospital admission may ameliorate adverse events associated with a hospital stay [5], 
allow signposting to a suitable cohort ward [30] or a trigger the need for comprehensive 
geriatric assessment [31]. It could also lead to extra care in communication with patients, 
especially around issues of capacity assessment and consenting for interventions.  
 
Conclusions 
Both the IQCODE-SF and AD8 are sensitive and specific tools to detect dementia in older 
people presenting to hospital with delirium. They are simple and quick to administer as well 
as being freely available.  Given the high prevalence of delirium in older people in hospital 
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the routine use of either tool in practice will have important clinical impact, potentially 
improving the formal recognition of dementia as well as having immediate implications for 
the inpatient care of this vulnerable population.  
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Table 1: Diagnostic test accuracy of the IQCODE-SF and AD8 at different cut-offs to diagnose dementia.  Sens=sensitivity, Spec=specificity, 
LR+ = positive likelihood ratio, LR- = negative likelihood ratio, AUROC=area under the receiver operating characteristic curve.  95% 
confidence intervals in brackets after all values. 
 Test/ 
cut off 
Sens Spec LR+ LR- AUROC 
Against diagnosis of 
dementia 
 
Prevalence 61% 
IQCODE 
≥3.44 
0.98 
(0.87-0.99) 
0.67 
(0.47-0.82) 
2.94 
(1.77-4.88) 
0.03 
(0.01-0.23) 
0.93 
(0.86-1.00, 
p<0.0005) 
IQCODE 
>3.82 
0.91 
(0.79-0.97) 
0.93 
(0.76-0.99) 
13.72 
(3.58-52.50) 
0.09 (0.04-
0.23) 
AD8  
>2 
0.97 
(0.87-0.99) 
0.40 
(0.23-0.60) 
1.63 
(1.21-2.19) 
0.05 
(0.01-0.41) 
0.91 
(0.83-0.98, 
P<0.0005) 
AD8 
>6 
0.83 
(0.69-0.92) 
0.90 
(0.72-0.97) 
8.30 
(2.81-24.47) 
0.19 
(0.09-0.36) 
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Figure 1: 
Flowchart of recruitment through study with demographics of recruited participants.  ♀ = 
female  
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Figure 2: 
Flow chart illustrating the use of the IQCODE-SF for screening patients with delirium for 
dementia in a hypothetical 1,000 bedded hospital and 10,000 non-elective admissions of older 
people yearly.  We expect 1700 (17 %) would have delirium, with 60% of those also having 
dementia.  33% of that dementia will be unrecognised.  We would expect 20% of patients to 
have no informant available. 
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